Skip to main content
. 2020 Sep 1;20:138. doi: 10.1186/s12894-020-00712-4

Table 2.

Projected impact of the validated EPI 15.6 and adjusted cut-points 20 and 29.6 (with presumed 100% compliance) on expected biopsies performed and avoided

EPI cut point Expected Biopsies Performed Expected Biopsies Avoided Delayed GG2 Delayed ≥GG3 NPV Sensitivity Specificity
15.6 170 (74%) 59 (26%) 2 3 91.5 (81.3–97.2) 82.1 (63.1–93.9) 26.9 (20.9–33.6)
20 149 (65%) 80 (35%) 2 3 93.8 (86.0–97.9) 82.1 (63.1–93.9) 37.3 (30.6–44.4)
29.6 89 (39%) 140 (61%) 2 6 93.6 (88.1–97.0) 67.9 (47.6–84.1) 65.2 (58.2–71.7)